Featuring experts Luke Gill, Will Chen and Rokuya Nochi

September 22, 2026
9:30am EDT / 6:30am PDT / 3:30pm CEST / 9:30pm China / 10:30pm Japan
Europe, US, APAC
Register Now
About This Webinar
Asia-Pacific offers unique advantages for global oncology programs — from large and diverse patient populations to streamlined regulatory pathways and cost-effective operations. This webinar brings together industry experts to explore how strategic integration of APAC capabilities can compress global development timelines, reduce costs, and improve regulatory success rates.
Attendees will gain practical insights into designing trials that leverage APAC’s strengths from the outset — eliminating the need for late-stage bridging studies and accelerating Proof-of-Concept decisions.
Accelerate Enrollment with APAC Patient Access: Tap into APAC’s large and diverse patient populations to accelerate recruitment timelines and enhance the generalizability of trial results.
Streamline Regulatory Pathways&Strengthen Regulatory Submissions: Navigate APAC’s evolving regulatory landscape to achieve faster trial initiation and filing readiness. Build a compelling global regulatory package with diverse patient data and real-world evidence from APAC markets.
Optimize Trial Design for Global Success: Structure trials with harmonized protocols and regional modules to support simultaneous global development and eliminate duplicate efforts.
Achieve Faster Proof-of-Concept Decisions: Integrate APAC sites from the beginning to generate robust data earlier, enabling quicker and more confident go/no-go decisions.